Last reviewed · How we verify
Oral Pyridoxine 10 mg
Oral Pyridoxine 10 mg is a Small molecule drug developed by National University of Malaysia. It is currently FDA-approved. Also known as: MSA Pyridoxine HCI 10 mg Tablet.
Oral Pyridoxine 10 mg, developed by the National University of Malaysia, is a marketed drug with a key composition patent expiring in 2028. The drug's primary strength lies in its established market presence and patent protection, which provides a competitive barrier until 2028. The primary risk is the potential increase in competition post-patent expiry in 2028.
At a glance
| Generic name | Oral Pyridoxine 10 mg |
|---|---|
| Also known as | MSA Pyridoxine HCI 10 mg Tablet |
| Sponsor | National University of Malaysia |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Maternal Supplementation From Preconception to Lactation on Child Growth and Development
- Evaluation of Fertitonex Effects on Semen Parameters in Clinical Varicocele Patient. (NA)
- Liposomal Iron 30 mg Supplement in Non-anemic Pregnant Females
- Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis
- Effects of a Colon-delivered Multivitamin Supplement on Brain Functioning, Immunometabolic- and Intestinal Markers in Ageing (NA)
- New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
- Efficacy of a Dietary Supplementation in Reducing Hospital Admissions for COVID-19. Randomized Clinical Trial (NA)
- Short Course Low Dose Oral Colchicine After ST Elevation Myocardial Infarction(STEMI) (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral Pyridoxine 10 mg CI brief — competitive landscape report
- Oral Pyridoxine 10 mg updates RSS · CI watch RSS
- National University of Malaysia portfolio CI
Frequently asked questions about Oral Pyridoxine 10 mg
What is Oral Pyridoxine 10 mg?
Who makes Oral Pyridoxine 10 mg?
Is Oral Pyridoxine 10 mg also known as anything else?
What development phase is Oral Pyridoxine 10 mg in?
Related
- Manufacturer: National University of Malaysia — full pipeline
- Also known as: MSA Pyridoxine HCI 10 mg Tablet
- Compare: Oral Pyridoxine 10 mg vs similar drugs
- Pricing: Oral Pyridoxine 10 mg cost, discount & access